New Zealand markets closed

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.35-0.19 (-1.22%)
As of 02:06PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-1,710
-61,286
-215,975
-167,870
-281,584
-
Depreciation & amortisation
10,654
5,552
2,026
3,344
2,932
-
Stock-based compensation
66,466
66,421
68,201
63,615
84,422
-
Change in working capital
-4,399
18,133
37,991
-24,824
11,036
-
Accounts receivable
-28,786
-36,072
2,171
-16,119
-12,466
-
Inventory
-45,937
-28,808
2,415
-4,210
-3,320
-
Accounts payable
1,910
4,797
5,870
-1,617
1,271
-
Other working capital
23,664
-23,348
-114,035
-126,782
-143,753
-
Other non-cash items
-
-
-
-
44,280
-
Net cash provided by operating activities
63,714
16,702
-114,035
-125,660
-136,166
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-40,050
-
-1,122
-7,587
-1,129
Purchases of investments
-383,247
-369,985
-363,174
-492,797
-339,908
-
Sales/maturities of investments
248,738
442,033
436,415
422,817
540,004
-
Net cash used for investing activities
-174,559
31,998
73,241
-71,102
192,509
-
Cash flows from financing activities
Common stock issued
24,706
25,129
8,199
18,162
80,996
-
Net cash used provided by (used for) financing activities
24,706
25,129
8,199
18,162
80,996
-
Net change in cash
-86,150
73,811
-32,589
-178,593
137,331
-
Cash at beginning of period
296,665
120,616
153,205
331,798
194,467
-
Cash at end of period
210,526
194,427
120,616
153,205
331,798
-
Free cash flow
Operating cash flow
63,714
16,702
-114,035
-125,660
-136,166
-
Capital expenditure
-
-40,050
-
-1,122
-7,587
-1,129
Free cash flow
23,664
-23,348
-114,035
-126,782
-143,753
-